Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose

Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose — setting out what I have, and where I think it stops being reliable.

I have read the maintained page on this and I still have a gap, so I am asking rather than guessing.

Context: tirzepatide, 21 weeks in, currently at a dose I reached by the standard four-week steps. Everything below is my own record rather than anything a clinician told me.

The specific question is the one in the title. What I have already checked: the labelling summary on the relevant documentation page, the two most-linked topics in this subcategory, and my own notes from the last 6 weeks. What I could not find is whether the answer changes at higher doses or whether it is the same arithmetic throughout.

If the answer is "it depends", I would rather know what it depends on than be given a number.

If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.

A new needle for each injection is not fussiness. A needle blunts on first use and a blunted needle is the reason the second injection hurts more than the first.

Post #3 answers the question as asked. The question underneath it is different.

I have no financial interest in anything named in this thread and I want to say so before I comment on Leak-back, because it is the sort of subject where it matters.

I had read the opposite somewhere and cannot now find where, which tells me something.

I would call the community position on Leak-back likely rather than established, and I would be comfortable defending that hedge.

Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your target dose, but some leak-back is universal and does not need to be treated as an error.

A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close, skip it and resume the schedule. The reasoning follows from the long half-life; you are perturbing a slowly moving average.

A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites, note the site with each dose. If a local reaction appears you have the history. If you rotate properly you will not get lipohypertrophy from overuse of one area.

The interesting part of this is the exception, and I do not understand the exception.

Adding the measurement that post #7 says would settle it.

Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose. The needle passed through tissue and there is a small amount of bleeding in the tract.

Worth one more sentence than it usually gets.

Picking up post #8: that is the part I would want checked first.

If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.

Note the site alongside the dose. If a local reaction appears three weeks later you will want to know where the previous four injections went.

It is worth stating the boring hypothesis before the interesting one.

I would keep Leak-back and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why the last one went badly.

Leak-back looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.